Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ARDELYX, INC. | Chief Commercial Officer | Common Stock | 449K | $3.51M | $7.81 | May 21, 2024 | Direct |
ARDELYX, INC. | Chief Commercial Officer | Stock Option (Right to Buy) | 145K | $336K | $2.32 | Jan 16, 2024 | Direct |
Veradigm Inc. | Director | Common Stock | 42.1K | $318K | $7.55 | May 31, 2024 | Direct |
HERON THERAPEUTICS, INC. /DE/ | Director | Stock Option (Right to Buy) | 83.7K | $149K | $1.78 | Jan 19, 2024 | Direct |
HERON THERAPEUTICS, INC. /DE/ | Director | Common Stock | 69.2K | $149K | $2.15 | Jan 19, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
MDRX | Veradigm Inc. | May 31, 2024 | 1 | $0 | 4 | Jun 20, 2024 | Director |
ARDX | ARDELYX, INC. | May 21, 2024 | 1 | -$52.4K | 4 | May 23, 2024 | Chief Commercial Officer |
ARDX | ARDELYX, INC. | Feb 20, 2024 | 1 | -$60.6K | 4 | Feb 22, 2024 | Chief Commercial Officer |
HRTX | HERON THERAPEUTICS, INC. /DE/ | Jan 19, 2024 | 2 | $0 | 4 | Jan 19, 2024 | Director |
ARDX | ARDELYX, INC. | Jan 16, 2024 | 2 | $0 | 4 | Jan 18, 2024 | Chief Commercial Officer |
ARDX | ARDELYX, INC. | Nov 20, 2023 | 1 | -$20.6K | 4 | Nov 22, 2023 | Chief Commercial Officer |
ARDX | ARDELYX, INC. | Aug 21, 2023 | 1 | -$16.8K | 4 | Aug 23, 2023 | Chief Commercial Officer |
ARDX | ARDELYX, INC. | May 23, 2023 | 1 | -$17.2K | 4 | May 25, 2023 | Chief Commercial Officer |
ARDX | ARDELYX, INC. | Feb 21, 2023 | 1 | -$16.8K | 4 | Mar 2, 2023 | Chief Commercial Officer |
MDRX | Veradigm Inc. | Feb 17, 2023 | 0 | $0 | 3 | Feb 27, 2023 | Director |
ARDX | ARDELYX, INC. | Jan 5, 2023 | 2 | $0 | 4 | Jan 6, 2023 | Chief Commercial Officer |
HRTX | HERON THERAPEUTICS, INC. /DE/ | Dec 16, 2022 | 2 | $0 | 4 | Dec 20, 2022 | Director |
ARDX | ARDELYX, INC. | Nov 22, 2022 | 3 | -$6.74K | 4 | Nov 23, 2022 | Chief Commercial Officer |
ARDX | ARDELYX, INC. | Aug 22, 2022 | 2 | -$3.36K | 4 | Aug 24, 2022 | Chief Commercial Officer |
ARDX | ARDELYX, INC. | Jun 6, 2022 | 2 | -$28.6K | 4 | Jun 8, 2022 | Chief Commercial Officer |
ARDX | ARDELYX, INC. | May 20, 2022 | 1 | -$2.3K | 4 | May 23, 2022 | Chief Commercial Officer |
ARDX | ARDELYX, INC. | Feb 22, 2022 | 1 | -$2.28K | 4 | Feb 25, 2022 | Chief Commercial Officer |
ARDX | ARDELYX, INC. | Jan 6, 2022 | 2 | $0 | 4 | Jan 12, 2022 | Chief Commercial Officer |
HRTX | HERON THERAPEUTICS, INC. /DE/ | Dec 22, 2021 | 2 | $0 | 4 | Dec 23, 2021 | Director |
ARDX | ARDELYX, INC. | Nov 22, 2021 | 1 | -$638 | 4 | Nov 24, 2021 | Chief Commercial Officer |
ARDX | ARDELYX, INC. | Oct 8, 2021 | 1 | $0 | 4 | Oct 29, 2021 | Chief Commercial Officer |
HRTX | HERON THERAPEUTICS, INC. /DE/ | Sep 20, 2021 | 0 | $0 | 3 | Sep 29, 2021 | Director |
ARDX | ARDELYX, INC. | Aug 20, 2021 | 1 | -$832 | 4 | Aug 24, 2021 | Chief Commercial Officer |
ARDX | ARDELYX, INC. | May 20, 2021 | 1 | -$4.33K | 4 | May 21, 2021 | Chief Commercial Officer |